Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Learn the best ways students can earn money fast with quick income solutions. Start boosting your finances today.
27,906 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Rivian is plotting a bold three-year arc that hinges on scale, software, and partnerships. This guide breaks down the...
Oracle isn't done spending on AI, and the move is shaking up how investors view cloud growth and profitability. This ...
A growing wave of aging business owners is approaching retirement, potentially reshaping communities. Experts say sel...
Anchorage draws retirees with rugged scenery, yet living costs and healthcare pose stiff tests for portfolios. A prac...
As AMD prepares to report its second-quarter results, a bullish outlook centered on AI demand could dominate the conv...
A prominent fund has taken a sizable stake in Kirby Corporation, with eyes on a bold earnings target of $6.33 per sha...
Nvidia has shown accelerating AI-driven demand that could push the stock higher. This article breaks down why the mar...
Regulatory clarity is on the horizon for digital assets as the Clarity Act advances. This guide breaks down three key...
The FIFA World Cup is fueling a new wave of activity in prediction markets. Kalshi is riding that momentum, turning t...
Investors face a stark choice in 2026: back an infrastructure-focused sand and logistics player in the Permian or bac...
This article analyzes Summit's Q4 2025 earnings context, what the numbers could imply for the summit (smmt) 2025 earn...